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Ubiquitin (Ub) is able to form polymeric isopeptide-linked chains through condensation of any of its
seven lysine (Lys) residues with the C-terminus of an adjacent Ub monomer. Electrospray ionisation
mass spectrometry (ESI-MS) of commercial in vitro-generated Lys48-linked di-Ub (Lys48-Ub2)
revealed a major population of cyclised dimer. The absence of a free C-terminus in this population
was conﬁrmed by an inability to bind the zinc ﬁnger ubiquitin-binding domain (ZnF-UBP) of USP5/
isopeptidase-T. Endogenous Ub2 puriﬁed from skeletal muscle and cultured mammalian cells was
found to contain cyclic Lys48-Ub2, demonstrating that cyclisation of poly-Ub can also occur in vivo.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction results in their coupling in the E2 active site. Notably however, toUbiquitination, a post-translational modiﬁcation (PTM) result-
ing in the covalent attachment of ubiquitin (Ub) to a target protein,
is a major regulatory mechanism in many eukaryotic cellular pro-
cesses [1]. Repetition of the ubiquitination cycle leads to the pro-
duction of polyubiquitin (poly-Ub) chains by formation of
isopeptide bonds utilizing any one of the seven Lys residues of
the Ub monomer, or the N-terminus, and the adjacent Ub’s
C-terminus [2]. Clear evidence is emerging that proteins labelled
with poly-Ub chains of a speciﬁc topology and length are driven
to speciﬁc processes. Lys48-linked poly-Ub chains, for example,
classically signal target protein degradation by the proteasome
[3]. Recently, a cyclic form of Lys48-linked di-Ub (Lys48-Ub2)
produced in vitro by the E2-25K Ub conjugating enzyme, has been
characterised [4], with in vitro-generated cyclic forms of Lys48-
Ub3 and -Ub4 having also been previously reported [5,6]. In each
of these species an additional isopeptide bond between the nor-
mally free C-terminal Gly76 of the proximal Ub, and Lys48 of the
distal Ub, is present. The close spatial proximity of these residues
in the compact conformations of Lys48-linked poly-Ub presumablychemical Societies. Published by E
oT, isopeptidase-T; ZnF, zinc
lectrospray ionisation-mass
ry, University of Nottingham,
0)115 951 3564.
.J. Oldham).date cyclic poly-Ub has not been identiﬁed in vivo, although
unanchored poly-Ub chains are abundant [7,8].
Here we demonstrate the presence of cyclic Ub2 as the major
component in a sample of commercial Lys48-Ub2. As predicted,
the cyclic Lys48-Ub2 was unable to bind the zinc ﬁnger (ZnF)
UBP (BUZ) Ub-binding domain (UBD) of USP5/isopeptidase-T
(isoT), from here onwards referred to as isoT–ZnF. IsoT is a highly
expressed deubiquitinating enzyme (DUB), which recognizes the
free C-terminal Gly76 of unanchored poly-Ub chains [9]. Using
an alternative UBD, the A20 ZnF domain from the ZNF216 protein,
which binds the Asp58 residue of Ub [10], we were also able to iso-
late and characterize endogenous cyclic Lys48-linked Ub2 from rat
skeletal muscle and cultured mammalian cells.
2. Materials and methods
2.1. Materials
Ultrapure water (18.2 MX cm), obtained from a Millipore water
puriﬁcation system (Epsom, UK), was used in the preparation of
sample solutions. Acetonitrile, formic acid and ammonium acetate
were purchased from ThermoFisher (Loughborough, UK). Lyophi-
lized Ub dimers (Lys11-Ub2 (Lot # 32141210), Lys48-Ub2 (Lot #
3291529 and Lot # 11515211) and Lys63-Ub2 (Lot # 1691689))
were obtained from Boston Biochem (Cambridge, USA) and pre-
pared as a 58 lM samples in 25 mM ammonium acetate solution.lsevier B.V. All rights reserved.
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Methods for the cloning, expression and puriﬁcation of human
isoT–ZnF and rat ZnF A20 (from ZNF216) UBDs were described pre-
viously [11].
2.3. Afﬁnity chromatography
Methods for the puriﬁcation of Ub dimers using the isoT–ZnF
and ZnF A20 domains from skeletal muscle were described previ-
ously [11]. For puriﬁcations from cultured cells, proteins (5 mg)
extracted from HEK293T cells were captured using the same ap-
proach using 50 lL of Sepharose-coupled ZnF A20 domain (protein
at 5 mg/mL).
2.4. Sample preparation
For ESI-MS analyses of commercial Ub dimers (Lys48, Lys63,
and Lys11-linked) proteins were prepared as 1 lM samples in
0.1% formic acid in 95:5 water-acetonitrile (v/v). For analysis of
ZnF A20 and isoT–ZnF domain-puriﬁed Ub dimers, samples were
eluted from Sepharose beads (50 lL) using 0.1% formic acid (ﬁnal
concentration), vortexed and incubated at room temperature (ap-
prox. 21 C) for 30 min followed by centrifugation (3600g for
10 min). An aliquot of the supernatant was removed and diluted
ﬁvefold with 0.1% formic acid in 95:5 water–acetonitrile.
For electrospray ionisation-mass spectrometry (ESI-MS) of non-
covalent complexes, desalting and buffer exchange of isoT–ZnF
into 25 mM NH4OAc buffer was achieved using Vivaspin 500
ultraﬁltration spin ﬁlters with a 10 kDa molecular weight cutoff
(Sartorius, Goettingen, Germany). Subsequent to buffer exchange
in 25 mMNH4OAc, isoT–ZnF was mixed with 0.5 mM dithiothreitol
(DTT) at 4 C for 24 h in order to reduce the disulﬁde-linked dimer
[9] to the monomeric domain. Reduced isoT–ZnF was mixed with
solutions of Lys48-Ub2 in NH4OAc (25 mM) to ﬁnal concentrations
of 2 and 1 lM, respectively.
2.5. Mass spectrometry
A Dionex nanoLC was interfaced with an LTQ FT-Ultra mass
spectrometer (ThermoFisher), operated in positive ion mode and
equipped with a standard Thermo nanospray ion source. The LC
trapping column was packed with C4 PepMap300 (Dionex) and
loaded using mobile phase A: Water/Acetonitrile (95:5, v/v) with
0.1% formic acid delivered at 20 lL min1. The trapping column
was switched in-line with the analytical column after a 3 min load-
ing time. Chromatographic separation was performed using a re-
verse phase C4 column (length 15 cm  75 lm i.d., manufactured
in house). Samples were eluted from the analytical column using
a linear gradient of B, a mixture of acetonitrile/water (95:5) with
0.1% formic acid, in buffer A, as follows: from 0% to 70% of buffer
B in 30 min, switched to 90% buffer B for 5 min, followed by
15 min re-equilibration with buffer A at a constant ﬂow rate of
0.2 lL min1. MS instrumental conditions were optimized using a
Ub2 standard. The heated capillary temperature was set at
200 C, the spray voltage was set at 1.6 kV and the capillary voltage
was held at 43 V. Data were acquired for Lys48, Lys63, and Lys11-
linked Ub2 standards following LC separation using full scan mode
(m/z 300–2000). Collision-induced dissociation (CID) of selected
protein charge states (15+, 17+ and 19+) was performed in the lin-
ear ion trap and fragments were subsequently transferred and
measured in the ICR cell. An isolation width of m/z = 8 was used
for selected protein charge states, which were subsequently acti-
vated for 30 ms using 18% normalized collision energy and an acti-
vation q of 0.25. A mass resolving power of 200,000 atm/z 400 wasused and Automatic Gain Control (AGC) was applied in all data
acquisition modes.
Experiments to observe the non-covalent isoT–ZnF  Lys48-Ub2
complex were performed on a SYNAPTTM HDMS (Waters, Altrinc-
ham, UK), a hybrid quadrupole ion mobility time-of-ﬂight MS
instrument, with travelling-wave ion mobility (TWIM) capability,
equipped with the standard z-spray source. Samples were infused
using a syringe pump (Harvard 22 dual syringe pump, model 55–
2222, Holliston, MA, USA) and a 100 lL Hamilton syringe (Bonaduz,
Switzerland), at a ﬂow rate of 5 lL min1. The ESI capillary voltage
was 2.6 kV; cone voltage, 60–80 V; extraction voltage, 5 V; transfer
voltage, 5 V. The source and desolvation temperatures were ad-
justed to 50 C. Cone and desolvation gas ﬂow rates were 30 and
200 L h1, respectively. Trap and transfer collision voltages were
8 and 5 V, respectively; backing pressure was set to 3.8–4.2 mbar;
the trap pressure was 2.1  102 mbar; and the TOF region
pressure 1.5  106 mbar.
3. Results
Analysis of commercial samples of in vitro generated native
Lys11, Lys63 and Lys48-Ub2 by ESI-MS resulted in the spectra
shown in Fig. 1A–C (only the [M+19H]19+ charge state is shown
for clarity). For Lys11 and Lys63 linkages a single charge distribu-
tion was observed with [M+19H]19+ at m/z 901.60, corresponding
to a molecular mass (Mr) of 17,111 Da (theoretical Mr 17,111 Da).
For Lys48-Ub2, however, two series were detected. Signals for
[M+19H]19+ ions occurred at m/z 901.60 and, additionally, at m/z
900.65 (Mr 17,093 Da). This second species was 18 Da lower than
the mass of the full polypeptide chain, which indicated dehydra-
tion. The presence of a dehydrated form of Lys48-Ub2 is consistent
with cyclisation of the C-terminus of the proximal Ub with the
Lys48 residue of the distal Ub. Cyclic Lys48-Ub3 has previously
been described as a product of in vitro ligation of Ub using E2-
25K [5], the E2 enzyme used to generate the dimer analysed here,
but here we show that cyclic Lys48-Ub2 is the major form (ca. 70%)
in the original batch of commercial native Lys48-Ub2 analysed by
us (Lot # 3291529). It should be noted that new batches of
Lys48-Ub2 (Lot # 11515211) contain much less cyclic material
(see Supporting Information Fig. S1), as a result of improved pro-
duction procedures implemented after our initial observations
(halting E2 catalysed polymerisation as soon as cyclic Lys48-Ub4
is observed).
Given that cyclisation blocks the C-terminal Gly76 residue of
Ub2 and that this motif is required for recognition by the isoT–
ZnF [9] we postulated that cyclic Lys48-Ub2 would not bind to this
UBD. To conﬁrm this hypothesis experimentally, puriﬁed isoT–ZnF
was mixed with commercial Lys48-Ub2 (Lot # 3291529) and the
resulting non-covalent complex analysed by ESI-MS under care-
fully optimised non-denaturing conditions [12]. Examination of
the resulting spectrum showed that only the acyclic form of
Lys48-Ub2 was able to associate with this UBD, forming a complex
we have previously studied by ESI-MS [12] (Supporting Informa-
tion Fig. S2). The more abundant cyclic Ub2 showed no interaction
with the iso-ZnF domain, conﬁrming our prediction, and support-
ing the original observation by Yao and Cohen that cyclic Lys48-
Ub3 is resistant to DUBs [5]. For the (Ub-associated) UBA2 domain
of hHR23A, and UBA domain of ubiquilin-1 (UQ1) which do not
recognise the free C-terminus of Ub, but instead target the Ile44-
centred hydrophobic patch, complexes were observed for both cyc-
lic and acyclic forms of Lys48-Ub2 using this methodology [12].
The presence of cyclic Lys48-Ub2 in a commercial sample pro-
duced by enzymatic ligation in vitro led us to consider whether
the cyclic form was also produced in vivo. Certainly unanchored
poly-Ub chains exist in cells and perform regulatory roles [7] and
Fig. 1. Electrospray ionisation mass spectra (ESI-MS) of intact (A) commercial Lys11-Ub2, (B) commercial Lys63-Ub2, (C) commercial Lys48-Ub2 and (D) Ub2 isolated from rat
skeletal muscle using immobilised the A20 ZnF domain (from ZNF216) showing the presence of cyclic Lys48-Ub2 in (C) and (D). Spectra were acquired under denaturing
conditions. Only the [M+19H]19+ ion is shown for clarity.
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can be puriﬁed using the isoT–ZnF domain [11]. Analysis of endog-
enous Ub dimers puriﬁed from rat skeletal muscle using the A20
ZnF UBD from the ZNF216 protein, using a protocol we have re-
cently developed [11], showed the presence of both the acyclic
and cyclic forms of Ub2 (Fig. 1D), with the latter representing
approximately 30% of the Lys48-Ub2 pool. Both, top-down and bot-
tom-up analyses have conﬁrmed endogenous rat muscle Ub2 to be
predominately Lys48-linked [11]. Tandem MS (MS/MS) of the
[M+17H]17+ precursor ion of each Ub2 commercial standard (m/z
1006.5–1007.5) led to the formation of b and y ions. Fig. 2 showsFig. 2. ESI-MS/MS spectra of the [M+17H]17+ precursor ions of (A) commercial Lys11-Ub
skeletal muscle using the A20 ZnF domain from ZNF216, and (E) Ub2 isolated from rat sk
cyclic form in (C) and (D). The isoT–ZnF domain is incapable of effectively capturing cycthe region of the mass spectra which contains the most abundant
ion, y58 [M+14H]14+ (m/z 1078.02). Fig. 2C and 2D illustrate the
additional peak at m/z 1076.73, which corresponded to the y58
[M+14H]14+ cyclic structure found only in the Lys48-Ub2 standard
and also in Ub2 from rat skeletal muscle captured by the A20 ZnF
domain. Endogenous Ub2 puriﬁed from muscle using the isoT–
ZnF domain contained only trace amounts of the cyclic form
(Fig. 2E), as expected by the requirement of isoT–ZnF for an acces-
sible Ub C-terminus. A20 ZnF UBD pull-downs from cultured
HEK293T cells also showed the presence of cyclic Lys48-Ub2 (Sup-
porting Information Fig. S3), permitting future pharmacological2, (B) commercial Lys63-Ub2, (C) commercial Lys48-Ub2, (D) Ub2 isolated from rat
eletal muscle using the isoT–ZnF domain. The major fragment ion, y5814+ exhibits a
lic Lys48-Ub2.
K. Sokratous et al. / FEBS Letters 586 (2012) 4144–4147 4147and molecular biological analyses of the regulation of cyclisation of
Ub. From these experiments it is clear that endogenous cyclic
Lys48-Ub2 is formed in vivo.
4. Discussion
The detection of endogenous cyclic Lys48-Ub2 in rat skeletal
muscle demonstrates that cyclisation is not simply an artefact
of in vitro production, but that the process also occurs in vivo.
Our analyses of commercial Ub2 samples with different isopep-
tide linkages revealed that the cyclic dimer was only detectable
in Lys48-linked samples, generated using E2-25K. Other linkage
types, generated by different E2s, contained only acyclic Ub2.
Further, in cyclic Ub dimers puriﬁed from muscle tissue (and
cultured mammalian cells) we detected the Lys48 linkage as a
major poly-Ub topology. Together, these observations suggest
that the Lys48 linkage is the predominant linkage type used in
cyclic poly-Ub in vivo, and that E2-25K could play a major role
in its generation.
In the original commercial samples of Lys48-Ub2 (Lot #
3291529) we analysed the cyclic product was present in signiﬁcant
quantity, representing as much as 70% of the total pool. It is impor-
tant to point out that the levels of cyclic material now appear much
lower (<20%) in the improved commercial product. Cyclic Lys48-
Ub2 is absent in material available from Enzo, a supplier that uses
modiﬁed [13] (as opposed to wild type sequence) Ub, to generate
poly-Ub in vitro (not shown).
In samples of endogenous Lys48-Ub2 puriﬁed from tissue or
cells the cyclic product represents as much as 30% of the total
Lys48-Ub2 pool. Although our study was limited to analysis of Ub
dimers, it will be of particular interest to determine if forms of cyc-
lic poly-Ub with more than two Ub moieties exist in vivo, and if so
their physiological roles (see below). It is important to point out
that bottom-up analysis of Ub-derived tryptic peptides would not
show the presence of cyclic Lys48-Ub2, which would appear as
two equivalents of the acyclic Lys48-Ub2 derived peptide LI-
FAGK(GG)QLEDGR. Knowledge that cyclic poly-Ub exists indicates
that absolute quantiﬁcation (AQUA) analyses of poly-Ub linkages
should be performed with caution.
Could the cyclic Lys48-Ub2 we have detected from tissue and
cell extracts represent an artefact that arises post-lysis and/or dur-
ing puriﬁcation, for example from E2-25K pre-charged with poly-
Ub chains? This seems unlikely given the relative abundance of
Ub dimers that we have noted in vivo and the care taken to avoid
adventitious proteolysis or Ub conjugation during the puriﬁcation
protocol [11]. We do include a DUB treatment step with the USP2
catalytic core when using the ZnF A20 domain to purify Ub-dimers,
in order to remove longer unanchored chains, but MS analyses
have conﬁrmed this does not alter levels nor the ratio of cyclic
compared to acyclic Lys48-Ub2 recovered (not shown). Indeed gi-
ven that cyclic poly-Ub lacks the free C-terminus on a proximal
Ub required by unanchored polyubiquitin chains for isoT-mediated
disassembly, it is likely to be relatively resistant to DUB activity. In-
deed in vitro-generated cyclic poly-Ub is known to be resistant to
many DUBs, but it is reported that red blood cell extract contains
an activity able to open and disassemble the cyclic chain [5].Hence, cyclic poly-Ub is unlikely to represent a dead-end product
in vivo.
So what could be physiological role(s) of unanchored cyclic
poly-Ub chains? In some ways cyclic poly-Ub could be viewed as
a variant of unanchored poly-Ub, for which a role in the activation
of protein kinases was not anticipated until very recently [7]. We
speculate that cyclic poly-Ub could represent a structurally unique
form of unanchored poly-Ub. Cyclic Lys48-Ub2 interacts with sev-
eral UBDs with a similar afﬁnity to that of the acyclic equivalent
[12], which hints at related functional properties, but with the abil-
ity of the former to be protected from disassembly by free chain
disassembling DUBs such as isoT.
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